Pathogen detection in acellular cerebrospinal fluid: diagnostic insights from a pediatric cohort in Colombia

Jhonny Jesús Patiño Patiño1,2, Elber Osorio-Rodríguez1,3, Yina Paola García Toscano1

  • 1Grupo Caribe de Investigación en Enfermedades de Tipo Infeccioso y Resistencia Microbiana, Universidad Metropolitana, Barranquilla, Colombia.

Microbiology Spectrum
|November 24, 2025
PubMed

Insights

Pediatric meningoencephalitis can be diagnosed using molecular testing even with normal cerebrospinal fluid (CSF) markers like pleocytosis. This approach aids in early detection of infections, including those caused by bacteria and viruses, improving patient outcomes.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Molecular Diagnostics

Background:

  • Pediatric meningoencephalitis diagnosis traditionally relies on cerebrospinal fluid (CSF) inflammatory markers, assuming infection always triggers an immune response.
  • This reliance may lead to missed diagnoses as some infections present without typical CSF abnormalities.

Purpose of the Study:

  • To evaluate the utility of molecular diagnostics (FilmArray Meningitis/Encephalitis panel) in pediatric meningoencephalitis.
  • To determine if central nervous system (CNS) infections can occur with normal CSF profiles.
  • To challenge the necessity of pleocytosis for justifying molecular testing.

Main Methods:

  • Prospective observational study of 166 pediatric patients with suspected meningoencephalitis in Cartagena, Colombia.
  • Comparison of FilmArray Meningitis/Encephalitis (FA-M/E) panel results with conventional CSF cytochemical analysis and culture.
  • Analysis of CSF profiles in patients with positive molecular results.

Main Results:

  • The FA-M/E panel identified pathogens in 12.6% of cases, while CSF cultures were negative.
  • No pleocytosis was observed in 100% of FA-M/E positive samples.
  • 7/21 (33.3%) of positive cases had normal CSF biochemistry, including bacterial and viral infections.

Conclusions:

  • Traditional CSF parameters are unreliable predictors of infection in pediatric meningoencephalitis.
  • Molecular diagnostics are crucial frontline tools, even without classical inflammatory CSF markers.
  • Early adoption of molecular testing can prevent delayed diagnosis and treatment in pediatric CNS infections.